Emergent BioSolutions stock reaffirms buy rating on contract modification
H.C. Wainwright & Co. reaffirmed its Buy rating and $15.00 price target for Emergent BioSolutions stock (NYSE:EBS). The ...
TipRanks on MSN6d
Shionogi Secures BARDA Funding for Long-Acting COVID-19 Antiviral Development
Shionogi & Co. has been awarded a $375 million project agreement by the Biomedical Advanced Research and Development ...
GlobalData on MSN2d
$590m to Moderna from HHS for mRNA ‘flu vax development
"$590m to Moderna from HHS for mRNA ‘flu vax development" was originally created and published by Pharmaceutical Technology, ...
BioWorld2d
Prepping for $1B in cuts, Moderna gets a $590M BARDA boost
While Moderna Inc. plans to cut its expenses by $1 billion in 2025, the company has received a little breathing room by a hefty U.S. Department of Health and Human Services (HHS) grant. The Biomedical ...
The Bakersfield Californian9d
Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode Bio to ...
Micron Biomedical, a life science company developing the world’s first needle-free technology for drugs and vaccines that is based on dissolvable microarrays, ...
Moderna confirms $590M award by U.S. for bird flu vaccine development
Moderna (MRNA) announced ongoing support from the U.S. Department of Health and Human Services, HHS, to accelerate the development of ...
Moderna Announces Updates on Pandemic Influenza Program
Moderna, Inc. (NASDAQ:MRNA) today announced ongoing support from the U.S. Department of Health and Human Services (HHS) to accelerate the development of mRNA-based pandemic influenza vaccines. The ...
Business Wire9d
Vaxxas Named Stage Winner of United States’ BARDA Prize to Advance Microarray Patches for Vaccination
The United States Biomedical Advanced Research and Development Authority (BARDA) has announced Vaxxas will receive US$2 million (AU$3.2 million) as a Concept Stage Winner in its multi-stage $50 ...
Business Insider10d
Emergent BioSolutions receives contract option valued at $16.7M
Emergent BioSolutions (EBS) announced that the Biomedical Advanced Research and Development Authority executed a contract modification for the second option period, valued at approximately $16.7 ...
The Bakersfield Californian9d
UPDATE - Micron Biomedical Wins $2 Million BARDA Competition for Its Collaboration with Zipcode ...
today announced the company won the Biomedical Advanced Research and Development Authority (BARDA) Patch Forward competition and presented at an event during the J.P. Morgan Healthcare Conference ...
Fort Worth Star-Telegram5d
Moderna Announces Updates on Pandemic Influenza Program
The award was made through the Rapid Response Partnership Vehicle (RRPV) Consortium with funding from the Biomedical Advanced Research and Development Authority (BARDA), part of the HHS ...
Joplin Globe10d
Vaxxas Named Stage Winner of United States’ BARDA Prize to Advance Microarray Patches for Vaccination
has been named a Concept Stage winner of the United States Biomedical Advanced Research and Development Authority’s (BARDA’s) $50 million Patch Forward Prize. This press release features ...